Admission Date:  [**2188-10-20**]              Discharge Date:   [**2188-11-3**]  Date of Birth:  [**2116-3-25**]             Sex:   F  Service: SURGERY  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 3376**] Chief Complaint: Rectal cancer.
History of Present Illness: The patient is a 72-year-old insulin- dependent diabetic with a BMI of 47, who was diagnosed with rectal cancer found to be T2, N0 by preoperative staging studies.
Anastomosis was not offered as the patient had limited mobility and walks with the aid of a walker and had some urgency and incontinence preoperatively.
She presented to the operating room on [**2188-10-20**] for laparoscopic converted to open proctectomy with colostomy.
Past Medical History: Colon adenoma, rectal adenocarcinoma, diabetes mellitus, peripheral neuropathy, hyperlipidemia, HTN, memory loss (likely small vessel ischemic disease), hyperparathyroidism, pulmonary sarcoidosis, anxiety/depression, agoraphobia with panic disorder   Social History: Patient lives with her husband in [**Name (NI) 745**], MA.
Physical Exam: Physical Exam on Discharge: Vitals: Temp 98, HR 51, BP 183/71, RR 18, O2 95RA Gen: In NAD, though appears anxious CV: No m/r/g Resp: CTA bilaterally Abd: 15 x 5 cm vertical midline incision with wound VAC in place to suction.
On VAC takedown, vertical midline wound is well granulating with fibrinous base.
Ext: 1+ bilateral pitting edema  Pertinent Results: [**2188-10-21**] 05:40AM BLOOD WBC-11.4* RBC-3.52* Hgb-11.3* Hct-31.6* MCV-90 MCH-32.2* MCHC-35.8*# RDW-13.1 Plt Ct-201 [**2188-10-22**] 05:15AM BLOOD WBC-18.0*# RBC-3.80* Hgb-12.1 Hct-34.1* MCV-90 MCH-31.9 MCHC-35.6* RDW-13.0 Plt Ct-248 [**2188-10-31**] 05:05AM BLOOD WBC-12.1* RBC-3.22* Hgb-10.0* Hct-30.3* MCV-94 MCH-31.0 MCHC-33.0 RDW-13.6 Plt Ct-357 [**2188-10-28**] 10:30AM BLOOD Neuts-82.3* Lymphs-10.2* Monos-6.6 Eos-0.6 Baso-0.2 [**2188-10-21**] 05:40AM BLOOD Glucose-155* UreaN-9 Creat-1.0 Na-138 K-4.3 Cl-102 HCO3-28 AnGap-12 [**2188-10-31**] 05:05AM BLOOD Glucose-90 UreaN-8 Creat-0.9 Na-142 K-3.7 Cl-108 HCO3-25 AnGap-13 [**2188-10-31**] 05:05AM BLOOD Calcium-7.9* Phos-2.9 Mg-2.1 .
SENSITIVITIES: MIC expressed in MCG/ML  _________________________________________________________                              MORGANELLA MORGANII                              | CEFEPIME--------------   <=1 S CEFTAZIDIME-----------   <=1 S CEFTRIAXONE-----------   <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------   <=1 S MEROPENEM-------------<=0.25 S TOBRAMYCIN------------   <=1 S TRIMETHOPRIM/SULFA----   <=1 S     ANAEROBIC CULTURE (Final [**2188-11-2**]):    NO ANAEROBES ISOLATED.
Respiratory: The patient had an elevated RR > 40 on [**2188-10-22**].
On exam she was in no acute distress, EKG and CXR were stable and she responded well to nebulizer treatments.
On discharge she was no longer requiring nebulizers.
On discharge she was no longer nauseous.
She was taken back to the OR on [**2188-10-22**] for fascial dehiscence.
Her wound was opened, washed out, the fascia was closed, and skin reapproximated.
However, following this procedure she continued to have purulent drainage from her wound.
GU: Postoperatively on [**10-28**] her foley cathether was discontinued, however she failed a voiding trial, and therefore her foley was replaced.
Given an equivocal urinalysis and yeast on urine culture, she was started on fluconazole, which was discontinued prior to discharge.
She did have purulent exudate from her vertical midline incision, and wound culture showed MORGANELLA MORGANII.
Her WBC count was downtrending on discharge and she remained afebrile on discharge.
Endocrine: Her finger stick glucoses remained elevated during admission, and she was evaluated by the [**Last Name (un) **] diabetes service who helped adjust her sliding scale.
Psych/Neuro: The patient was transferred to the SICU on [**2188-10-22**] for altered mental status.
The service evaluated her and felt she has agoraphobia with panic disorder, and recommended her home citalopram be increased from 20 mg daily to 30 mg daily.
5. lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours) as needed for anxiety.
Disp:*10 * Refills:*0* 14. oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 hours) as needed for pain for 3 weeks.
Disp:*40 * Refills:*0*   Discharge Disposition: Extended Care  Facility: [**Hospital 745**] Health Care Center  Discharge Diagnosis: T2, N0 rectal cancer Morbid obesity.
You have tolerated a regular diet, passing gas and your pain is controlled with pain medications by mouth.
?s to have some decrease in bowel function but your should not have prolonged constipation.
Some loose stool and passing of small amounts of dark, old appearing blood are explected however, if you notice that you are passing bright red blood with bowel movments or having loose stool without improvement please call the office or go to the emergency room if the symptoms are severe.
Please take an over the counter stool softener such as Colace, and if the symptoms does not improve call the office.
If you have any of the following symptoms please call the office for advice or go to the emergency room if severe: increasing abdominal distension, increasing abdominal pain, nausea, vomiting, inability to tolerate food or liquids, prolonges loose stool, or constipation.
You have a long vertical incision on your abdomen that is closed with a VAC dressing.
Please monitor the incision for signs and symptoms of infection including: increasing redness at the incision, opening of the incision, increased pain at the incision line, draining of white/green/yellow/foul smelling drainage, or if you develop a fever.
Please call the office if you develop these symptoms or go to the emergency room if the symptoms are severe.
You will be prescribed a small amount of the pain medication.
Do not drink alcohol while taking narcotic pain medication or Tylenol.
You may take an over the counter stool softener such as colace if you find that you are becoming constipated from narcotic pain medications.
The stoma (intestine that protrudes outside of your abdomen) should be beefy red or pink, it may ooze small amounts of blood at times when touched and this should subside with time.
The skin around the ostomy site should be kept clean and intact.
Monitor the skin around the stoma for buldging or signs of infection listed above.
